Amkor Technology (AMKR)
NASDAQInformation TechnologySemiconductorsSnapshot 2026-10-29
$41.21-2.37%
Close 2026-10-29 · 1-day change
NASDAQInformation TechnologySemiconductorsSnapshot 2026-10-29
Research Workspace
Put AMKR beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Semiconductors is in expansion. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Revenue reaches at least $1.8 billion in Q2 2026: Revenue: $1.99B.
View ThesisRevenue growth is accelerating — up about 16% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is highly volatile — it swings about 3% on a typical day and fell roughly 61% in its worst 12-month stretch.
View RiskAMKR’s advanced packaging and test capacity is the central growth bet, supported by strong recent performance. Revenue grew year over year in Q1 and Q2, though growth eased slightly; Q3 earnings missed consensus. The shares trade at 17× P/E versus a 56× peer median and their own historical 23× multiple. The price reflects less growth than our forecast, despite the premium gap to peers. A Q3 earnings miss and a 20% next-quarter miss probability challenge the thesis. Revenue also remains the pressured pillar, despite Q2 revenue exceeding its threshold. Peer multiples imply a price about 28% above where it trades; the thesis is on watch, and this read is provisional.
Trailing returns as of 2026-10-29. AMKR is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 11 analysts currently covering AMKR (as of Oct 2026).
Based on 4 Wall Street analysts offering 12-month price targets for AMKR in the last 4 months.
Continue this research
Compare AMKR with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| AMKR Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 11 valuation methods, at three horizons. As of 2026-10-29. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Semiconductors — fair value, gap to price, and forward P/E.
Our valuation methods disagree too much on this name right now. Rather than print a number we don't believe, we're holding it back until they converge.
Compare the value case
Put AMKR next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Expand advanced packaging and test capacity
Reported Nvidia advanced-packaging expansion supports demand for Amkor's capacity, but details are limited.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-29. EPS is implied from price ÷ P/E. Not investment advice.
Current $41.21
The last 12 months of price, then the range of analyst 12-month targets from today’s $41.21.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Advances: Expand advanced packaging and test capacity
Increased demand aligns with advanced packaging growth objective.
Advances: Expand advanced packaging and test capacity
Expansion aligns with growth objective and enhances capacity.
Advances: Expand advanced packaging and test capacity
Expansion of advanced packaging capacity aligns with growth objectives.
Threatens: Expand advanced packaging and test capacity
Delay in NVIDIA deal impacts advanced packaging growth plans.
Advances: Strengthen strategic partnerships with earlier design engagement
Expansion may enhance strategic partnerships and customer engagement.
Advances: Expand advanced packaging and test capacity
AI-focused packaging aligns with advanced packaging expansion objective.
AI surge aligns with revenue growth and market potential.
